Spyre Therapeutics SYRE
NASDAQ SYRE
$91.50 -1.45 (-1.56%)
As of: Oct 22, 2026 · 12:51 PM EDT

Spyre Therapeutics (SYRE) Other financing activities (2016 - 2026)

Updated

Spyre Therapeutics (SYRE) reported Other financing activities of $1,000 for FY2024, compared with -$16,000 in FY2023.

Analysis

Spyre Therapeutics (SYRE) Other financing activities (2016 - 2026) Analysis & Trends

  • According to Business Quant data, Other financing activities came in at -$16,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 Spyre Therapeutics 7.75 Bn 4.62 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -283,000.00
Mar 31, 2026 -171,000.00
Dec 31, 2025 -69,000.00
Sep 30, 2025 -5.25 Mn
Mar 31, 2025 -93,000.00
Dec 31, 2024 -328,000.00
Sep 30, 2024 -78,000.00
Mar 31, 2024 -1.43 Mn
Dec 31, 2023 -5.80 Mn
Mar 31, 2016 -98,000.00
API Access

Spyre Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=SYRE&period=max&api_key=YOUR_API_KEY